Full Text View  
  Tabular View  
  Contacts and Locations  
  No Study Results Posted  
  Related Studies  
Comparison of the Effects of Phenylephrine and Norepinephrine on Cardiac Function During Carotid Artery Surgery
This study is currently recruiting participants.
Verified by Lawson Health Research Institute, February 2006
Sponsored by: Lawson Health Research Institute
Information provided by: Lawson Health Research Institute
ClinicalTrials.gov Identifier: NCT00294606
  Purpose

This will be a prospective, randomized, double-blinded, cross-over clinical trial to compare the effects of phenylephrine or norepinephrine on cardiac function during carotid artery surgery in patients under general anesthesia. The effect of the vasopressor on cardiac function will be measured using electrocardiography, transesophageal echocardiography and cardiac troponin I intraoperatively and postoperatively. We will use a cross-over pattern since both drugs exhibit rapid onset and short duration of action. We hypothesize that there will be less myocardial ischemia associated with the use of norepinephrine when compared with phenylephrine during carotid artery surgery.


Condition Intervention
Vasopressor Agents
Endarterectomy, Carotid
Echocardiography, Transesophageal
Drug: Comparison of Effects of Phenylephrine and Norepinephrine

MedlinePlus related topics: Anesthesia
Drug Information available for: Phenylephrine Guaifenesin Naphazoline Naphazoline hydrochloride Oxymetazoline Oxymetazoline hydrochloride Phenylephrine hydrochloride Phenylpropanolamine Phenylpropanolamine hydrochloride Norepinephrine Norepinephrine bitartrate
U.S. FDA Resources
Study Type: Interventional
Study Design: Randomized, Double-Blind, Active Control, Crossover Assignment
Official Title: Comparison of the Effects of Phenylephrine and Norepinephrine on Cardiac Function During Carotid Cross-Clamping During Carotid Endarterectomy Under General Anesthesia

Further study details as provided by Lawson Health Research Institute:

Primary Outcome Measures:
  • Myocardial ischemia measures by transesophageal echocardiography and ST segment analyses

Secondary Outcome Measures:
  • Myocardial ischemia measures by cardiac troponin I

Estimated Enrollment: 86
Study Start Date: February 2006
Estimated Study Completion Date: February 2006
  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Elective carotid endarterectomy under general anesthesia
  • > 18 years old
  • Written informed consent

Exclusion Criteria:

  • Contraindication to general anesthesia
  • Contraindication to transesophageal anesthesia
  • esophageal disease
  • esophageal stricture
  • history of esophageal or gastric bleeding
  • esophageal anatomic abnormality
  • past esophageal or gastric surgery
  • severe dysphagia
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00294606

Contacts
Contact: Rosemary A Craen, MD, FRCPC (519) 663-3022 rosemary.craen@lhsc.on.ca
Contact: Hélène G Pellerin, MD, FRCPC (519) 663-3022 hpelleri@uwo.ca

Locations
Canada, Ontario
University Hospital, LHSC Recruiting
London, Ontario, Canada, N6A 5A5
Contact: Rosemary A Craen, MD, FRCPC     (519) 663-3022     Rosemary.Craen@lhsc.on.ca    
Principal Investigator: Rosemary A Craen, MD, FRCPC            
Sponsors and Collaborators
Lawson Health Research Institute
Investigators
Principal Investigator: Rosemary A Craen, MD, FRCPC Associate Professor University of Western Ontario
  More Information

Study ID Numbers: R-05-941
Study First Received: February 17, 2006
Last Updated: February 17, 2006
ClinicalTrials.gov Identifier: NCT00294606  
Health Authority: Canada: Health Canada

Keywords provided by Lawson Health Research Institute:
vasopressor agents
carotid endarterectomy
cardiac function
transesophageal echocardiography
wall motion abnormalities

Study placed in the following topic categories:
Pseudoephedrine
Naphazoline
Oxymetazoline
Guaifenesin
Phenylephrine
Norepinephrine
Ephedrine
Phenylpropanolamine
Congenital Abnormalities

Additional relevant MeSH terms:
Respiratory System Agents
Neurotransmitter Agents
Adrenergic alpha-Agonists
Adrenergic Agents
Molecular Mechanisms of Pharmacological Action
Sympathomimetics
Cardiotonic Agents
Physiological Effects of Drugs
Cardiovascular Agents
Protective Agents
Adrenergic Agonists
Pharmacologic Actions
Nasal Decongestants
Anti-Obesity Agents
Mydriatics
Autonomic Agents
Expectorants
Therapeutic Uses
Vasoconstrictor Agents
Appetite Depressants
Peripheral Nervous System Agents
Central Nervous System Agents

ClinicalTrials.gov processed this record on January 16, 2009